Necitumumab

Portrazza

16 MG / ML SolutionCanadaCancelled

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

PORTRAZZA 800mg concentrado para solucion para perfusionSpain · 800 mg · concentrado para solución para perfusión · Eli Lilly Nederland B.V.Same brand
PortrazzaEuropean Union · Eli Lilly Nederland B.V.Same brand
Portrazza, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Eli Lilly Nederland BVSame brand
PortrazzaUnited States · 800MG/50ML · injectable · Eli Lilly CoSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Necitumumab

Portrazza

16 MG / ML SolutionCanadaCancelled

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Necitumumab
Strength: 16 MG / ML
Dosage form: Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Pre Market
Registration: DIN 02462478
Marketing authorisation holder: Eli Lilly Canada INC
ATC code: L01FE03
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION, SCHEDULE D